What is Perrigo Company?
Founded in 1887 and headquartered in Dublin, Ireland, Perrigo Company operates as a global supplier and manufacturer of private label over-the-counter pharmaceuticals. The company plays a crucial role in the healthcare supply chain, providing accessible and affordable health and wellness solutions to consumers worldwide. Its extensive product portfolio spans various therapeutic categories, positioning it as a key player in both the pharmaceutical and consumer goods sectors.
How much funding has Perrigo Company raised?
Perrigo Company has raised a total of $1B across 1 funding round:
Stock Offering
$1B
Stock Issuance/Offering (2014): $1B, investors not publicly disclosed
What's next for Perrigo Company?
Given Perrigo Company's 'major enterprise-level funding' context and its long-standing history, the company appears to be in a mature growth phase, likely focused on strategic acquisitions, market expansion, and product innovation. The substantial capital raised historically suggests a capacity for significant operational scaling and R&D investment. Future strategic moves may involve further consolidation within the private label pharmaceutical space or diversification into adjacent healthcare markets. The company's ability to leverage its established manufacturing capabilities and distribution networks will be critical for sustained growth and maintaining its competitive edge in the dynamic global healthcare landscape.
See full Perrigo Company company page
